PT Bio Farma
Pre-Approval PRO BETAPipeline by Phase
Therapeutic Focus
Clinical Trials (35)
Immunogenicity and Safety Following In-House Recombinant Hepatitis B Vaccine in Indonesian Population (Phase III)
Started: 9/1/2025
Immunogenicity and Safety of DTP-HB-Hib Using New Hepatitis B Bulk (Bio Farma)
Started: 12/1/2025
Safety and Immunogenicity of SARS-CoV-2 Protein Subunit Recombinant Vaccine in Healthy Children
Started: 10/9/2022
Immuno-bridging Study of COVID-19 Protein Subunit Recombinant Vaccine
Started: 6/7/2022
Efficacy, Safety and Immunogenicity of Rotavirus RV3 Vaccine (Bio Farma) in Neonates
Started: 10/30/2020
Comparison of Immunogenicity and Safety of DTP-HB-Hib (Bio Farma) With Pentabio® Vaccine Primed With Recombinant Hepatitis B
Started: 10/13/2020
Efficacy, Safety and Immunogenicity Study of SARS-CoV-2 Inactivated Vaccine
Started: 8/10/2020
Immunogenicity and Safety of Vi-DT (Diphtheria Toxoid) Typhoid Conjugate Vaccine (Phase III)
Started: 3/2/2020
Protectivity and Safety of DTP/HB/Hib (Bio Farma) Vaccines in Infants, Batch Consistency, Multi Center Trial
Started: 8/1/2012
Homologous Booster Study of COVID-19 Protein Subunit Recombinant Vaccine
Started: 7/25/2023
Heterologous Booster Study of COVID-19 Protein Subunit Recombinant Vaccine in Children 12-17 Years of Age
Started: 2/28/2023
Persistence and Long-Term Protection of Vi Antibodies Induced by Vi-DT Conjugate Vaccines in Indonesian
Started: 5/3/2021
Booster Study of COVID-19 Protein Subunit Recombinant Vaccine
Started: 9/1/2022
Safety and Immunogenicity Study of COVID-19 Protein Subunit Recombinant Vaccine
Started: 4/13/2022
Protectivity and Safety Following Recombinant Hepatitis B Vaccine
Started: 9/11/2019
Safety and Tuberculin Conversion Following BCG Vaccination
Started: 12/1/2021
Safety and Immunogenicity of Vi-DT Typhoid Conjugate Vaccine in Indonesian Adults, Adolescents, Children and Infants
Started: 7/16/2018
Immunogenicity & Safety of Bio Farma's Measles-Rubella (MR) Vaccine in Indonesian Infants (Bridging Study)
Started: 9/3/2019
Protectivity and Safety of Quadrivalent Influenza HA Vaccine in Indonesian Population
Started: 11/21/2017
Immunogenocity and Safety of Flubio (Influenza HA) Vaccine in Infants and Children (Bridging Study)
Started: 5/1/2014
Antibody Persistence, Immune Response and Safety After Doses of Pentabio Vaccine
Started: 3/1/2014
Evaluation on Immunogenicity and Safety Profile of Trivalent OPV (tOPV Bio Farma)
Started: 5/1/2013
Immunogenicity and Safety of DTP/HB/Hib (Bio Farma)Compared to DTP/HB Given Simultaneously With Hib(Registered)Vaccine
Started: 7/1/2011
Phase I/II, Open Label, Randomized, Safety and Immunogenicity Following DTwP-Hepatitis B-Hib-IPV Vaccine (Bio Farma) in Indonesian Infants
Started: 3/1/2025
Safety and Immunogenicity Study of COVID-19 Protein Subunit Recombinant Vaccine Adjuvanted With Alum+CpG 1018
Started: 2/16/2022
Safety and Immunogenicity of SARS-CoV-2 Protein Subunit Recombinant Vaccine
Started: 12/10/2021
Safety and Immunogenicity Following Recombinant Hepatitis B (Bio Farma) Vaccine in Adults & Children
Started: 12/3/2019
Safety and Immunogenicity of Rotavirus (Bio Farma) Vaccine in Adults, Children & Neonates
Started: 4/9/2018
Safety and Immunogenicity of Vi-DT Typhoid Conjugate Vaccine (Bio Farma) in Adults and Children (Phase I)
Started: 4/18/2017
The Safety and Immunogenicity of DTP/Hepatitis B 10ug Hib Vaccine (Bio Farma)
Started: 4/1/2011
Effectiveness & Safety of Ovine Enoxaparin Sodium to Originator Enoxaparin in Non-ST-Segment Elevation ACS Patients
Started: 6/1/2023
Post Marketing Surveillance of Diphtheria Antitoxin (DAT)
Started: 1/31/2023
Reactogenicity and Protectivity Following Measles- Rubella (MR) Routine Immunization in Indonesian Infants and Children
Started: 11/16/2017
Immunogenicity and Safety Profile of Primary Dose of bOPV Bio Farma Given Simultaneously With Pentabio And IPV
Started: 7/1/2016